Pisa syndrome associated with mirtazapine: a case report

被引:3
作者
Yamada, Yuji [1 ]
Takano, Harumasa [1 ,2 ]
Yamada, Maki [1 ]
Satake, Naoko [1 ]
Hirabayashi, Naotsugu [1 ]
Okazaki, Mitsutoshi [1 ]
Nakagome, Kazuyuki [3 ]
机构
[1] Natl Ctr Hosp, Natl Ctr Neurol & Psychiat, Dept Psychiat, 4-1-1 Ogawahigashi Cho, Kodaira, Tokyo 1878551, Japan
[2] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Clin Neuroimaging, Kodaira, Tokyo, Japan
[3] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Tokyo, Japan
关键词
Mirtazapine; Side-effects; Dystonia; Pisa syndrome; Bipolar disorder; BRAIN NEUROTRANSMITTERS; SEROTONIN;
D O I
10.1186/s40360-018-0272-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundMirtazapine is a noradrenergic and specific serotonergic antidepressant; its pharmacological profile indicates a low risk for dopaminergic adverse effects. To date, there has been only a single case report of Pisa syndrome associated with mirtazapine.Case presentationThe authors report a case involving a 79-year-old woman with bipolar disorder, in whom Pisa syndrome occurred after introduction of mirtazapine, and completely disappeared 3days after suspension of the drug.ConclusionsAspects of this particular case suggest that Pisa syndrome is a possible side effect of Mirtazapine.
引用
收藏
页数:3
相关论文
共 14 条
[1]   Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France [J].
Bondon-Guitton, Emmanuelle ;
Perez-Lloret, Santiago ;
Bagheri, Haleh ;
Brefel, Christine ;
Rascol, Olivier ;
Montastruc, Jean-Louis .
MOVEMENT DISORDERS, 2011, 26 (12) :2226-2231
[2]  
deBoer T, 1996, J CLIN PSYCHIAT, V57, P19
[3]   Tardive dystonic syndrome induced by the calcium-channel blocker amlodipine [J].
Dressler, Dirk .
JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (04) :367-369
[4]   NEW DYSTONIC SYNDROME ASSOCIATED WITH BUTYROPHENONE THERAPY [J].
EKBOM, K ;
LJUNGBERG, L ;
LINDHOLM, H .
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (02) :94-+
[5]   BRAIN NEUROTRANSMITTERS IN DYSTONIA MUSCULORUM DEFORMANS [J].
HORNYKIEWICZ, O ;
KISH, SJ ;
BECKER, LE ;
FARLEY, I ;
SHANNAK, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (06) :347-353
[6]   PHARMACOLOGICAL CHARACTERIZATION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) [J].
HYTTEL, J .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 :19-26
[7]  
JANKOVIC J, 1987, NEW ENGL J MED, V316, P278
[8]   Dystonia induced by mirtazapine [J].
Lu, R ;
Hurley, AD ;
Gourley, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (05) :452-453
[9]   Acute Pisa Syndrome After Administration of a Single Dose of Mirtazapine [J].
Mendez Guerrero, Antonio ;
Llamas, Sara ;
Jose Murcia, Francisco ;
Ruiz, Juan .
CLINICAL NEUROPHARMACOLOGY, 2013, 36 (04) :133-134
[10]   Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation [J].
Nakayama, K ;
Sakurai, T ;
Katsu, H .
BRAIN RESEARCH BULLETIN, 2004, 63 (03) :237-241